Biotechnology is an exploding category for investors. With so many companies to choose from it can be difficult to discern the flash in the pans from those with staying power. We ran a screen of biotech stocks that are showing real promise. The criteria we employed today were solid and strong profits with the added bonus of a recent rating of 'Buy' or 'Strong Buy' from industry analysts. The list below is a great place to start your research.
Return on Assets [ROA] illustrates how much a company is generating in earnings from its assets alone. This metric gives investors a picture of how profitable the company is relative to the assets in current possession. As well, it lets investors see how efficient and effective management is at generating earnings from the company's assets. While most management teams can probably make money by throwing money at an issue very few
... Read the rest at SeekingAlpha.com
No comments:
Post a Comment